Invesco’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $456K | Buy |
40,207
+14,024
| +54% | +$159K | ﹤0.01% | 3194 |
|
|
2025
Q1 | $174K | Buy |
26,183
+14,118
| +117% | +$93.9K | ﹤0.01% | 3532 |
|
|
2024
Q4 | $133K | Buy |
+12,065
| New | +$133K | ﹤0.01% | 3571 |
|
|
2024
Q3 | – | Sell |
-437,136
| Closed | -$5.91M | – | 3861 |
|
|
2024
Q2 | $5.91M | Buy |
+437,136
| New | +$5.91M | ﹤0.01% | 2088 |
|
|
2022
Q2 | – | Sell |
-131,674
| Closed | -$2.77M | – | 4100 |
|
|
2022
Q1 | $2.77M | Buy |
+131,674
| New | +$2.77M | ﹤0.01% | 2638 |
|
|
2021
Q4 | – | Sell |
-9,325
| Closed | -$237K | – | 4061 |
|
|
2021
Q3 | $237K | Buy |
9,325
+1,323
| +17% | +$33.6K | ﹤0.01% | 3705 |
|
|
2021
Q2 | $269K | Buy |
+8,002
| New | +$269K | ﹤0.01% | 3649 |
|
|
2021
Q1 | – | Sell |
-25,329
| Closed | -$1.57M | – | 3895 |
|
|
2020
Q4 | $1.57M | Buy |
+25,329
| New | +$1.57M | ﹤0.01% | 2726 |
|